• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis.弥散基谱成像和弥散张量成像预测多发性硬化症中永久性黑洞的形成。
Mult Scler Relat Disord. 2024 Apr;84:105494. doi: 10.1016/j.msard.2024.105494. Epub 2024 Feb 11.
2
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole.急性多发性硬化病变的弥散度增加预示着黑洞形成的风险。
Neurology. 2010 May 25;74(21):1694-701. doi: 10.1212/WNL.0b013e3181e042c4.
3
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.对患有多发性硬化症的患者的T1黑洞进行4年每月一次成像的演变情况。
Brain. 2003 Aug;126(Pt 8):1782-9. doi: 10.1093/brain/awg182. Epub 2003 Jun 23.
4
Diffusion basis spectrum imaging for identifying pathologies in MS subtypes.弥散张量谱成像在 MS 亚型中的应用。
Ann Clin Transl Neurol. 2019 Nov;6(11):2323-2327. doi: 10.1002/acn3.50903. Epub 2019 Oct 6.
5
Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.扩散张量谱成像检测早期帕金森病患者黑质和白质束的病理改变。
Eur Radiol. 2023 Dec;33(12):9109-9119. doi: 10.1007/s00330-023-09780-0. Epub 2023 Jul 12.
6
Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions.基于扩散基谱成像的深度学习用于多发性硬化病变分类。
Ann Clin Transl Neurol. 2020 May;7(5):695-706. doi: 10.1002/acn3.51037. Epub 2020 Apr 18.
7
Utility of Diffusion Basis Spectrum Imaging in Quantifying Baseline Disease Severity and Prognosis of Cervical Spondylotic Myelopathy.弥散张量频谱成像在定量评估脊髓型颈椎病基线疾病严重程度和预后中的应用。
Spine (Phila Pa 1976). 2022 Dec 15;47(24):1687-1693. doi: 10.1097/BRS.0000000000004456. Epub 2022 Aug 15.
8
Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema.在存在额外纤维细胞增多和血管源性水肿的情况下量化白质束扩散参数。
Neuroimage. 2014 Nov 1;101:310-9. doi: 10.1016/j.neuroimage.2014.06.064. Epub 2014 Jul 11.
9
Diffusion MRI Metrics Characterize Postoperative Clinical Outcomes After Surgery for Cervical Spondylotic Myelopathy.扩散加权磁共振成像指标可表征脊髓型颈椎病手术后的临床预后。
Neurosurgery. 2025 Jan 1;96(1):69-77. doi: 10.1227/neu.0000000000003037. Epub 2024 Jun 21.
10
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes.大剂量甲基强的松龙治疗多发性硬化症复发可减少增强病变进展为持续黑洞。
J Neurol. 2018 Mar;265(3):522-529. doi: 10.1007/s00415-017-8726-2. Epub 2018 Jan 11.

引用本文的文献

1
Conventional and Advanced Magnetic Resonance Imaging Biomarkers of Multiple Sclerosis in the Brain.大脑中多发性硬化症的传统和先进磁共振成像生物标志物
Cureus. 2025 Mar 2;17(3):e79914. doi: 10.7759/cureus.79914. eCollection 2025 Mar.

本文引用的文献

1
Phase 1 Evaluation of C-CS1P1 to Assess Safety and Dosimetry in Human Participants.评估C-CS1P1在人体受试者中安全性和剂量测定的1期试验
J Nucl Med. 2022 Nov;63(11):1775-1782. doi: 10.2967/jnumed.121.263189. Epub 2022 Mar 24.
2
Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN.早期接受 peginterferon beta-1a 治疗的反应与复发缓解型多发性硬化症患者的长期临床结局相关: ADVANCE 和 ATTAIN 的亚组分析。
Mult Scler Relat Disord. 2022 Jan;57:103367. doi: 10.1016/j.msard.2021.103367. Epub 2021 Nov 3.
3
Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.血清神经丝轻链与多发性硬化症的髓鞘和轴索磁共振成像标志物相关。
Mult Scler Relat Disord. 2022 Jan;57:103366. doi: 10.1016/j.msard.2021.103366. Epub 2021 Nov 3.
4
Positron emission tomography in multiple sclerosis - straight to the target.正电子发射断层扫描在多发性硬化中的应用——直击靶标。
Nat Rev Neurol. 2021 Nov;17(11):663-675. doi: 10.1038/s41582-021-00537-1. Epub 2021 Sep 20.
5
Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.应用弛豫和弥散基谱成像技术对多发性硬化的神经炎症和神经退行性变进行特征描述。
Mult Scler. 2022 Mar;28(3):418-428. doi: 10.1177/13524585211023345. Epub 2021 Jun 16.
6
Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.多发性硬化症中炎症、轴突和髓鞘损伤的无创定量。
Brain. 2021 Feb 12;144(1):213-223. doi: 10.1093/brain/awaa381.
7
Diffusion basis spectrum imaging provides insights into MS pathology.弥散张量谱成像为 MS 病理学提供了新视角。
Neurol Neuroimmunol Neuroinflamm. 2019 Dec 23;7(2). doi: 10.1212/NXI.0000000000000655. Print 2020 Mar.
8
Diffusion basis spectrum imaging for identifying pathologies in MS subtypes.弥散张量谱成像在 MS 亚型中的应用。
Ann Clin Transl Neurol. 2019 Nov;6(11):2323-2327. doi: 10.1002/acn3.50903. Epub 2019 Oct 6.
9
Imaging B Cells in a Mouse Model of Multiple Sclerosis Using Cu-Rituximab PET.使用铜标记的利妥昔单抗PET对多发性硬化症小鼠模型中的B细胞进行成像。
J Nucl Med. 2017 Nov;58(11):1845-1851. doi: 10.2967/jnumed.117.189597. Epub 2017 Jul 7.
10
Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.聚乙二醇化干扰素β-1a可改善复发缓解型多发性硬化症患者的磁共振成像指标,并提高无疾病活动证据患者的比例:ADVANCE随机对照试验的2年结果
BMC Neurol. 2017 Feb 10;17(1):29. doi: 10.1186/s12883-017-0799-0.

弥散基谱成像和弥散张量成像预测多发性硬化症中永久性黑洞的形成。

Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis.

机构信息

Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Department of Neurology, VA Portland Health Care System, Portland, OR, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

Department of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA; Department of Biostatistics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Mult Scler Relat Disord. 2024 Apr;84:105494. doi: 10.1016/j.msard.2024.105494. Epub 2024 Feb 11.

DOI:10.1016/j.msard.2024.105494
PMID:38359694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978237/
Abstract

BACKGROUND AND OBJECTIVES

Diffusion basis spectrum imaging (DBSI) extracts multiple anisotropic and isotropic diffusion tensors, providing greater histopathologic specificity than diffusion tensor imaging (DTI). Persistent black holes (PBH) represent areas of severe tissue damage in multiple sclerosis (MS), and a high PBH burden is associated with worse MS disability. This study evaluated the ability of DBSI and DTI to predict which acute contrast-enhancing lesions (CELs) would persist as T hypointensities (i.e. PBHs) 12 months later. We expected that a higher radial diffusivity (RD), representing demyelination, and higher DBSI-derived isotropic non-restricted fraction, representing edema and increased extracellular space, of the acute CEL would increase the likelihood of future PBH development.

METHODS

In this prospective cohort study, relapsing MS patients with ≥1 CEL(s) underwent monthly MRI scans for 4 to 6 months until gadolinium resolution. DBSI and DTI metrics were quantified when the CEL was most conspicuous during the monthly scans. To determine whether the CEL became a PBH, a follow-up MRI was performed at least 12 months after the final monthly scan.

RESULTS

The cohort included 20 MS participants (median age 33 years; 13 women) with 164 CELs. Of these, 59 (36 %) CELs evolved into PBHs. At Gd-max, DTI RD and AD of all CELs increased, and both metrics were significantly elevated for CELs which became PBHs, as compared to non-black holes (NBHs). DTI RD above 0.74 conferred an odds ratio (OR) of 7.76 (CI 3.77-15.98) for a CEL becoming a PBH (AUC 0.80, CI 0.73-0.87); DTI axial diffusivity (AD) above 1.22 conferred an OR of 7.32 (CI 3.38-15.86) for becoming a PBH (AUC 0.75, CI 0.66-0.83). DBSI RD and AD did not predict PBH development in a multivariable model. At Gd-max, DBSI restricted fraction decreased and DBSI non-restricted fraction increased in all CELs, and both metrics were significantly different for CELs which became PBHs, as compared to NBHs. A CEL with a DBSI non-restricted fraction above 0.45 had an OR of 4.77 (CI 2.35-9.66) for becoming a PBH (AUC 0.74, CI 0.66-0.81); a CEL with a DBSI restricted fraction below 0.07 had an OR of 9.58 (CI 4.59-20.02) for becoming a PBH (AUC 0.80, 0.72-0.87).

CONCLUSION

Our findings suggest that greater degree of edema/extracellular space in a CEL is a predictor of tissue destruction, as evidenced by PBH evolution.

摘要

背景与目的

扩散基础谱成像(DBSI)提取多个各向异性和各向同性扩散张量,比弥散张量成像(DTI)提供更高的组织病理学特异性。持续黑洞(PBH)代表多发性硬化症(MS)中严重的组织损伤区域,较高的 PBH 负担与更严重的 MS 残疾相关。本研究评估了 DBSI 和 DTI 预测急性对比增强病变(CEL)中哪些病变将在 12 个月后持续为 T 低信号(即 PBH)的能力。我们预计,急性 CEL 的径向扩散度(RD)升高(代表脱髓鞘)和 DBSI 衍生的各向同性无限制分数升高(代表水肿和细胞外空间增加),会增加未来 PBH 发展的可能性。

方法

在这项前瞻性队列研究中,≥1 个 CEL(s)的复发型 MS 患者接受了 4 至 6 个月的每月 MRI 扫描,直到钆增强消退。当 CEL 在每月扫描中最明显时,对 DBSI 和 DTI 指标进行了量化。为了确定 CEL 是否会变成 PBH,在最后一次每月扫描后至少 12 个月进行了随访 MRI。

结果

该队列包括 20 名 MS 参与者(中位年龄 33 岁;13 名女性),共 164 个 CEL。其中,59 个(36%)CEL 演变为 PBH。在 Gd-max,所有 CEL 的 DTI RD 和 AD 均增加,且成为 PBH 的 CEL 的这两项指标均显著高于非黑洞(NBH)。RD 高于 0.74 的 DTI 为 CEL 成为 PBH 的比值比(OR)为 7.76(CI 3.77-15.98)(AUC 0.80,CI 0.73-0.87);AD 高于 1.22 的 DTI 为 CEL 成为 PBH 的 OR 为 7.32(CI 3.38-15.86)(AUC 0.75,CI 0.66-0.83)。在多变量模型中,DBSI RD 和 AD 均不能预测 PBH 的发展。在 Gd-max,所有 CEL 的 DBSI RD 和 AD 均降低,且成为 PBH 的 CEL 的这两项指标均显著低于 NBH。DBSI 非限制分数高于 0.45 的 CEL 成为 PBH 的 OR 为 4.77(CI 2.35-9.66)(AUC 0.74,CI 0.66-0.81);DBSI 限制分数低于 0.07 的 CEL 成为 PBH 的 OR 为 9.58(CI 4.59-20.02)(AUC 0.80,0.72-0.87)。

结论

我们的研究结果表明,CEL 中更大程度的水肿/细胞外空间是组织破坏的预测因子,这一点从 PBH 的演变中可以看出。